Key facts
- This page summarizes Andy Sassine's Form 4 filing for Arcturus Therapeutics Holdings Inc. (ARCT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 18 Dec 2024, 16:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
Footnote F2
The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.